돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 3036생성일: 2026년 10월 24일

Pyridine, hydrofluoride (1:1) → methyl(11R,12S,13E)-9-butyryloxy-11,15-dihydroxy-16,16,20-trimethyl-7-thiaprosta-8,13-dienoate

https://huagongshe.com/ko/reaction/3036

반응식

참여 물질

역할이름HCID투입량
반응물Pyridine, hydrofluoride (1:1)HCID 64774—
반응물methyl(11R,12S,13E)-9-butyryloxy-11-tert-butyldimethylsiloxy-15-hydroxy-16,16,20-trimethyl-7-thiaprosta-8,13-dienoateHCID 22883818—
생성물methyl(11R,12S,13E)-9-butyryloxy-11,15-dihydroxy-16,16,20-trimethyl-7-thiaprosta-8,13-dienoateHCID 22883815—

반응 단계

Using as the materials a hydrogen fluoride-pyridine solution (0.25 ml) and methyl(11R,12S,13E)-9-butyryloxy-11-tert-butyldimethylsiloxy-15-hydroxy-16,16,20-trimethyl-7-thiaprosta-8,13-dienoate (100 mg), the same procedure as in Example 2 was performed to separately obtain two stereoisomers of methyl(11R,12S,13E)-9-butyryloxy-11,15-dihydroxy-16,16,20-trimethyl-7-thiaprosta-8,13-dienoate different at the 15-position. (Low polarity compound: 26 mg, 33%; high polarity compound: 28 mg, 35%)

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US05731452
출처 데이터셋uspto-grants-1998_03
ORD IDord-e387f53034b342bebeac204bcb29c54a
출처 메모uspto-grants-1998_03